Question · asked by 1 review

Summary of findings table ‐ Continuation vs reduction of polypharmacy: Hospital readmission

Population
patients with schizophrenia
Intervention
Summary of findings table ‐ Continuation
Comparison
reduction of polypharmacy
Outcome
Hospital readmission

It is very uncertain whether summary of findings table ‐ Continuation changes service use – readmission to hospital – total compared with reduction of polypharmacy (very low certainty).

What each review found

Include earlier review versions
FindingEffectStudiesGRADE certainty
Summary of findings table ‐ Continuation vs reduction of polypharmacy
Service use – readmission to hospital – total · people with schizophrenia
It is very uncertain whether summary of findings table ‐ Continuation changes service use – readmission to hospital – total compared with reduction of polypharmacy (very low certainty).
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia (2022) · Cochrane Headline outcomes only
RR 0.75 [0.25, 2.24]1 study · 127 participantsVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
2022 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed
How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.